350 results
All patients with type 1 diabetes require life-long insulin due to absent or near-absent beta-cell function. Insulin therapy in patients with type 1 diabetes should ideally be managed with an endocrinologist.
Read about a new study supporting use of direct oral anticoagulants (DOACs) for patients with valvular atrial fibrillation, including its limitations, in this EBM Focus article.
Insulin therapy is often required in the treatment of diabetes but there is much to consider when prescribing it, starting with which condition is prompting the need.
Patients are reporting lingering symptoms after acute COVID-19. Read about post-acute COVID-19 syndrome (PACS) also known as long COVID.
Read a brief synopsis of a recent blog post from our partner IBM Watson Health on artificial intelligence (AI) enabled clinical decision support and access the full article.
The World Health Organization recently endorsed the first malaria vaccine, but malaria prevention remains a difficult endeavor. DynaMed® Medical Writer Keri Sheehan, Ph.D., explores this new development in malaria prevention.
Molnupiravir is a new antiviral pill to treat COVID-19. Here’s what we know so far.
The EBM Focus team at DynaMed® discusses a large cohort study evaluating risk of myocarditis after COVID vaccination.
Mixed evidence for procalcitonin to identify bacterial infections contributes to the confusion over whether it is useful. Read about a new pragmatic trial evaluating procalcitonin with or without point-of-care ultrasound for suspected pneumonia.
Will Estimating GFR Without Adjusting for Race Help to Reduce Racial Bias in Chronic Kidney Disease?
Estimating glomerular filtration rate (GFR) includes adjusting for race, leading to disparities in care of Black patients with kidney disease. The team at DynaMed® examines this racial bias.